federal_register: 2023-27312
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-27312 | Methodological Challenges Related to Patient Experience Data; Summary of Received Comments | Notice | The Food and Drug Administration (FDA) is announcing the availability of a summary on the comments received for the "Methodological Challenges Related to Patient Experience Data; Request for Information and Comments" notice published on May 2, 2023. The input received in response to the Request for Information will help FDA plan two public workshops focused on methodological challenges and will help FDA identify priorities for future work. | 2023-12-13 | 2023 | 12 | https://www.federalregister.gov/documents/2023/12/13/2023-27312/methodological-challenges-related-to-patient-experience-data-summary-of-received-comments | https://www.govinfo.gov/content/pkg/FR-2023-12-13/pdf/2023-27312.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a summary on the comments received for the "Methodological Challenges Related to Patient Experience Data; Request for Information and Comments" notice published on May 2, 2023.... |